🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the service has removed violative content and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of joining one community, a seller posted contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Product Details and Costs

Within these groups, posts display black plastic parcels with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously encountered patients harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.